-
New Real-World Case Series Examines Re-Induction with ADSTILADRIN® (nadofaragene firadenovec-vncg) in Clinical Practice
Re-induction with ADSTILADRIN resulted in complete responses in 31% of initial non-responders with Bacillus Calmette-Guérin…
-
ICSC Announces Inaugural ICSC Tech Innovator Awards at ICSC+PROPTECH
--(BUSINESS WIRE)--ICSC: ATTN: Retail/Real Estate/Business Editors and Reporters WHO: ICSC WHAT: ICSC will present its…
-
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Selects MEVION S250-FIT™ for Southern Italy’s First Proton Therapy Center
Compact, vault-integrated platform selected through a competitive European tender will bring proton therapy to patients…
-
AVL Hosts Virtual Salon Suite Exploring How IVF Research Inspired a New Era of Science-Backed Skincare
NEW YORK--(BUSINESS WIRE)--#AVLaboratories--AV Laboratories, the science-backed skincare brand redefining the intersection of science, skincare, and…
-
ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory for the Tokyo Strain of BCG to Enhance BCG Supply in the United States
Positive Phase III readout of National Cancer Institute sponsored SWOG S1602 randomized clinical trial demonstrating…
-
TetraMem Announces 22nm Multi-Level RRAM Analog In-Memory Computing SoC Milestone
SAN JOSE, Calif.--(BUSINESS WIRE)--#AI--TetraMem Inc., a Silicon Valley–based semiconductor company developing analog in-memory computing (IMC)…
-
Dr. Reddy’s Laboratories Launches its Generic Semaglutide Injection in Canada
The launch follows Dr. Reddy’s receipt of the Notice of Compliance (NOC) from Health Canada…
-
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US for two new indications for patients with HER2-positive early breast cancer
Approved for use before surgery based on DESTINY-Breast11 Phase III trial Approved for use following…
-
Starbucks Corporation Announces Early Results and Upsizing of its Tender Offers for Eight Series of Notes
SEATTLE--(BUSINESS WIRE)--Starbucks Corporation (Nasdaq: SBUX) (“Starbucks,” “we,” “us” or the “Company”) today announced the early…
-
Metropolitan Issues Statement on Increased State Water Project Allocation
LOS ANGELES--(BUSINESS WIRE)--Metropolitan Water District General Manager Shivaji Deshmukh issues the following statement on the…
-
ARMSTRONG WORLD INDUSTRIES, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Armstrong…
-
BLACK ROCK COFFEE BAR, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Black…
-
MedX Announces Final Closing of Non-brokered Private Placement
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce…
-
Rosen Law Firm Encourages Cencora, Inc. Investors to Inquire About Securities Class Action Investigation – COR
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation…
-
KBRA Assigns Preliminary Ratings to GreenSky Home Improvement Issuer Trust 2026-REV1
NEW YORK--(BUSINESS WIRE)--#creditratingagency--KBRA assigns preliminary ratings to four classes of notes issued by GreenSky Home…
-
INVESTOR ALERT: Securities Class Action Filed Against Phreesia, Inc. – Investors Encouraged to Contact Kirby McInerney LLP
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit…
-
Faraday Future Announces $25 Million in New Financing, Demonstrating Institutional Investors’ Confidence in the Company’s Prospects; Recent Total of $70 Million in Financing to Sufficiently Support the Phase I Goals of Its Robotics Business Plan
Combined with the $45 million announced in April, the Company has secured a total of…
-
Sidecar Health Supports CMS Decision to Remove Network Requirement for ACA Exchange Plans
ACA exchange enrollees will now have access to insurance models built around transparency and open…
-
Enhertu® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer
Approved for use before surgery based on DESTINY-Breast11 phase 3 trial or following surgery based…
-
Liberty Broadband Corporation Declares Quarterly Cash Dividend on Series A Cumulative Redeemable Preferred Stock
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Liberty Broadband Corporation (Nasdaq: LBRDA, LBRDK, LBRDP) today announced that its Board of…